{"id":"https://openalex.org/W4244978489","doi":"https://doi.org/10.1002/14651858.cd005225.pub3","title":"Creatine for amyotrophic lateral sclerosis/motor neuron disease","display_name":"Creatine for amyotrophic lateral sclerosis/motor neuron disease","alternate_titles":[],"publication_year":2012,"publication_date":"2012-12-12","ids":{"openalex":"https://openalex.org/W4244978489","doi":"https://doi.org/10.1002/14651858.cd005225.pub3"},"language":"en","primary_location":{"id":"doi:10.1002/14651858.cd005225.pub3","doi":"https://doi.org/10.1002/14651858.cd005225.pub3","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd005225.pub3","pdf_url":null,"source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4244978489"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018093518","display_name":"Daniel M. Pastula","orcid":"https://orcid.org/0000-0001-9342-4459","observed_orcids":["https://orcid.org/0000-0001-9342-4459"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210110664","display_name":"University of California San Francisco Medical Center","ror":"https://ror.org/01t8svj65","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110664"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel M Pastula","raw_affiliation_strings":["UCSF Medical Center; Neurology; UCSF Neurology, Box 0114 505 Parnassus Ave San Francisco California USA 94143-0114"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Medical Center; Neurology; UCSF Neurology, Box 0114 505 Parnassus Ave San Francisco California USA 94143-0114","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210110664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059617881","display_name":"Dan H. Moore","orcid":"https://orcid.org/0000-0002-5860-0127","observed_orcids":["https://orcid.org/0000-0002-5860-0127"]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dan H Moore","raw_affiliation_strings":["California Pacific Medical Center; Research Institute; 475 Brannan St Suite 220 San Francisco CA USA 94107"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Pacific Medical Center; Research Institute; 475 Brannan St Suite 220 San Francisco CA USA 94107","institution_ids":["https://openalex.org/I2801780550"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102998448","display_name":"Richard Bedlack","orcid":"https://orcid.org/0000-0003-4666-7495","observed_orcids":["https://orcid.org/0000-0003-4666-7495"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard S Bedlack","raw_affiliation_strings":["Duke Medical Center; Division of Neurology; Box 3333 Durham USA NC 27707"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Medical Center; Division of Neurology; Box 3333 Durham USA NC 27707","institution_ids":["https://openalex.org/I4210126298"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5100,"currency":"USD","value_usd":5100},"apc_paid":null,"fwci":0.3426,"has_fulltext":false,"cited_by_count":50,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.26712644,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"2012","issue":"12","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10441","display_name":"Muscle Physiology and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/creatine","display_name":"creatine","score":0.9399999976158142},{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/motor-neuron-disease","display_name":"motor neuron disease","score":0.9990000128746033},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.75},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.8939999938011169},{"id":"https://openalex.org/keywords/alsfrs-r","display_name":"ALSFRS-R","score":0.8949999809265137},{"id":"https://openalex.org/keywords/forced-vital-capacity","display_name":"forced vital capacity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/atp-production","display_name":"ATP production","score":0.5270000100135803},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6000000238418579},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5299999713897705},{"id":"https://openalex.org/keywords/renal-failure-risk","display_name":"renal failure risk","score":0.5830000042915344},{"id":"https://openalex.org/keywords/creatine-supplementation","display_name":"creatine supplementation","score":0.34299999475479126},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.36399999260902405}],"concepts":[{"id":"https://openalex.org/C2780596555","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Amyotrophic lateral sclerosis","level":3,"score":0.8776724338531494},{"id":"https://openalex.org/C2779896295","wikidata":"https://www.wikidata.org/wiki/Q223600","display_name":"Creatine","level":2,"score":0.8499861359596252},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7668560743331909},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6547101736068726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5494290590286255},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5138640403747559},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4919984042644501},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.46863341331481934},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.46506741642951965},{"id":"https://openalex.org/C2778466831","wikidata":"https://www.wikidata.org/wiki/Q206901","display_name":"Motor neurone disease","level":4,"score":0.41742292046546936},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.41057440638542175},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.16220435500144958},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.08518385887145996}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/14651858.cd005225.pub3","doi":"https://doi.org/10.1002/14651858.cd005225.pub3","is_oa":false,"landing_page_url":"https://doi.org/10.1002/14651858.cd005225.pub3","pdf_url":null,"source":{"id":"https://openalex.org/S4210172715","display_name":"Cochrane Database of Systematic Reviews","issn_l":"1361-6137","issn":["1361-6137","1464-780X","1465-184X","1465-1858","1469-493X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-1","jufo-2","ki-jl-2","medline","norway-1","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cochrane Database of Systematic Reviews","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W1565043637","https://openalex.org/W1598602811","https://openalex.org/W1964692300","https://openalex.org/W1971797190","https://openalex.org/W1975792093","https://openalex.org/W1977984194","https://openalex.org/W1988236146","https://openalex.org/W1996703483","https://openalex.org/W2008177239","https://openalex.org/W2014433622","https://openalex.org/W2019031549","https://openalex.org/W2025650182","https://openalex.org/W2029102402","https://openalex.org/W2032219491","https://openalex.org/W2033528195","https://openalex.org/W2045319154","https://openalex.org/W2046177286","https://openalex.org/W2067155827","https://openalex.org/W2067856511","https://openalex.org/W2076766906","https://openalex.org/W2096386031","https://openalex.org/W2108381339","https://openalex.org/W2109712577","https://openalex.org/W2111453406","https://openalex.org/W2122459736","https://openalex.org/W2137490547","https://openalex.org/W2145330051","https://openalex.org/W2152847494","https://openalex.org/W2160421939","https://openalex.org/W2161938104","https://openalex.org/W2164229456","https://openalex.org/W2167105734","https://openalex.org/W2169484757","https://openalex.org/W2178313645","https://openalex.org/W2276148590","https://openalex.org/W2314689571","https://openalex.org/W2756307401","https://openalex.org/W2906992465","https://openalex.org/W3147894994","https://openalex.org/W4233081346","https://openalex.org/W4236884331","https://openalex.org/W4244907084","https://openalex.org/W7036618593"],"related_works":["https://openalex.org/W2152847494","https://openalex.org/W2107667281","https://openalex.org/W1991148105","https://openalex.org/W2067856511","https://openalex.org/W2122459736","https://openalex.org/W2289505977","https://openalex.org/W2159695871","https://openalex.org/W2014367499","https://openalex.org/W1964692300"],"abstract_inverted_index":{"Background":[0],"Creatine,":[1],"a":[2,52,266,313,333,354,405],"naturally\u2010occurring":[3],"nitrogenous":[4],"organic":[5],"acid":[6],"involved":[7],"in":[8,19,58,69,74,97,119,128,145,166,235,246,276,301,323,340,349],"adenosine":[9],"triphosphate":[10],"(ATP)":[11],"production,":[12],"has":[13],"been":[14,40],"shown":[15],"to":[16,104,111,219,223,263,397],"increase":[17],"survival":[18,72,155,277],"mouse":[20],"models":[21],"of":[22,48,66,122,139,194,254,320,346],"amyotrophic":[23],"lateral":[24],"sclerosis":[25],"(ALS),":[26],"also":[27,125],"known":[28],"as":[29,162,366],"motor":[30],"neuron":[31],"disease":[32,77],"(MND).":[33],"Results":[34],"from":[35,206,395],"human":[36],"trials,":[37],"however,":[38],"have":[39,404],"mixed.":[41],"Given":[42],"conflicting":[43],"results":[44,210],"regarding":[45],"the":[46,64,83,98,120,129,233,279,305,324,341,350,360],"efficacy":[47,65,68],"creatine,":[49],"we":[50,231,237,271,296],"conducted":[51],"systematic":[53],"review,":[54],"which":[55,363],"was":[56,153,243,332,372],"updated":[57,232],"2012.":[59],"Objectives":[60],"To":[61],"systematically":[62],"examine":[63],"creatine":[67,118,142,221,282,325,342,351,391],"prolonging":[70],"ALS":[71,76,160,167],"and":[73,107,173,185,196,201,281],"slowing":[75],"progression.":[78,417],"Search":[79],"methods":[80],"We":[81,124,199,211],"searched":[82],"Cochrane":[84,99],"Neuromuscular":[85],"Disease":[86],"Group":[87],"Specialized":[88],"Register":[89],"(16":[90],"July":[91,105,112],"2012),":[92],"CENTRAL":[93],"(2012,":[94],"issue":[95],"7":[96],"Library),":[100],"MEDLINE":[101],"(January":[102,109],"1966":[103],"2012)":[106,113],"EMBASE":[108],"1980":[110],"for":[114,131],"any":[115,132],"trial":[116],"involving":[117,215],"treatment":[121,140],"ALS.":[123,149],"contacted":[126],"experts":[127],"field":[130],"additional":[133,240],"studies.":[134],"Selection":[135],"criteria":[136],"Randomized":[137],"trials":[138,214],"with":[141,148,251,385],"or":[143,228,257,388,413],"placebo":[144,280],"patients":[146,382],"diagnosed":[147,384],"Our":[150],"primary":[151],"outcome":[152],"tracheostomy\u2010free":[154],"time;":[156],"secondary":[157],"outcomes":[158],"were":[159],"progression":[161,412],"measured":[163],"by":[164],"changes":[165],"functional":[168],"rating":[169],"revised":[170],"scores":[171],"(ALSFRS\u2010R)":[172],"per":[174,226,400],"cent":[175],"predicted":[176,415],"forced":[177],"vital":[178],"capacity":[179],"(FVC)":[180],"over":[181],"time.":[182],"Data":[183],"collection":[184],"analysis":[186],"Two":[187],"authors":[188],"independently":[189],"selected":[190],"studies,":[191,250],"assessed":[192],"risk":[193],"bias":[195],"extracted":[197],"data.":[198],"obtained":[200],"analyzed":[202],"individual":[203],"participant":[204],"data":[205],"each":[207],"study.":[208],"Main":[209],"included":[212,249,364],"three":[213,248,286,310],"386":[216],"participants":[217],"randomized":[218],"either":[220],"5":[222,396],"10":[224,398],"g":[225,399],"day":[227,401],"placebo.":[229],"When":[230],"searches":[234],"2012":[236],"found":[238,272,297],"no":[239,252,273,298],"trials.":[241],"Creatine":[242],"reportedly":[244],"well\u2010tolerated":[245],"all":[247,285,309],"evidence":[253],"renal":[255],"failure":[256],"serious":[258],"adverse":[259],"events":[260],"specifically":[261],"attributable":[262],"creatine.":[264],"Using":[265],"pooled":[267,314,355],"log\u2010rank":[268],"statistical":[269,274,299],"test,":[270],"difference":[275,300,319,345,371],"between":[278,304],"groups":[283,307],"across":[284,308,359],"studies":[287,311,362],"(Chi2":[288],"=":[289,292,328,377],"0.09,":[290],"P":[291,327],"0.76).":[293,329],"In":[294,381],"addition,":[295],"ALSFRS\u2010R":[302,411],"slopes":[303],"two":[306,361],"using":[312,353],"linear":[315,356],"mixed\u2010effects":[316,357],"model":[317,358],"(slope":[318,344],"+0.03":[321],"ALSFRS\u2010R/month":[322],"group;":[326],"Interestingly,":[330],"there":[331],"trend":[334],"towards":[335],"slightly":[336],"worsened":[337],"FVC":[338,365,416],"slope":[339],"group":[343],"\u20100.63":[347],"FVC/month":[348],"group)":[352],"an":[367],"outcome,":[368],"but":[369],"this":[370],"not":[373,403],"statistically":[374,406],"significant":[375,407],"(P":[376],"0.054).":[378],"Authors'":[379],"conclusions":[380],"already":[383],"clinically":[386],"probable":[387],"definite":[389],"ALS,":[390],"at":[392],"doses":[393],"ranging":[394],"did":[402],"effect":[408],"on":[409],"survival,":[410],"percent":[414]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4244978489","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-05-12T00:00:00"}
